• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Biotec Pharmacon ASA

+ Add to Watchlist

B4V:GR

2.174 EUR 0.026 1.18%

As of 03:06:13 ET on 04/17/2014.

Snapshot for Biotec Pharmacon ASA (B4V)

Open: 2.203 Day's Range: 2.174 - 2.203 Volume: 0
Previous Close: 2.200 52wk Range: 0.485 - 2.750 1-Yr Rtn: +281.40%

Stock Chart for B4V

No chart data available.
  • B4V:GR 2.174
  • 1D
  • 1M
  • 1Y
2.200
Interactive B4V Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for B4V

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -0.4100
Est. PEG Ratio -
Market Cap (M EUR) 94.43
Shares Outstanding (M) 43.44
30 Day Average Volume 1,169
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for B4V

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for B4V

Biotec Pharmacon ASA develops, manufactures and markets immune modulating compounds for the human and animal health sectors and marine enzymes used in molecular biology. The Company develops products to prevent or treat diseases caused by the failure, imbalance, and over-reaction of the immune system.

Svein W F LienChief Executive OfficerArvid VangenCFO/CAO
Rolf EngstadCSO
More Company Profile & Key Executives for B4V

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil